Capricor Therapeutics (CAPR) Capital Expenditures Growth (3y) (2016 - 2026)
Capricor Therapeutics (CAPR) Capital Expenditures Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Capricor Therapeutics |
1.53 Bn |
1.26 Bn |
- |
145.14% |
| Date | Value |
|---|
| Mar 31, 2026 |
145.14% |
| Dec 31, 2025 |
33.86% |
| Sep 30, 2025 |
-53.56% |
| Jun 30, 2025 |
16.72% |
| Mar 31, 2025 |
16.44% |
| Dec 31, 2024 |
9.86% |
| Sep 30, 2024 |
-73.07% |
| Jun 30, 2024 |
-42.80% |
| Mar 31, 2024 |
154.52% |
| Dec 31, 2023 |
24.69% |
| Sep 30, 2023 |
21.03% |
| Jun 30, 2023 |
8.13% |
| Dec 31, 2021 |
194.88% |
| Sep 30, 2021 |
47.65% |
| Jun 30, 2021 |
1,006.54% |
| Mar 31, 2021 |
-41.71% |
| Sep 30, 2020 |
110.28% |
| Jun 30, 2020 |
103.72% |
| Sep 30, 2018 |
129.35% |
| Mar 31, 2018 |
169.97% |
